B of A Securities Maintains Buy on Hims & Hers Health, Lowers Price Target to $20
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Michael Cherny maintains a Buy rating on Hims & Hers Health (NYSE:HIMS) but lowers the price target from $24 to $20.
September 13, 2024 | 4:52 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
B of A Securities maintains a Buy rating on Hims & Hers Health but lowers the price target from $24 to $20, indicating a positive outlook with some caution.
The Buy rating suggests confidence in the company's prospects, but the lowered price target indicates some caution about future performance. This mixed signal may lead to neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100